Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20.
17. Januar 2024Kresken M, Pfeifer Y, Wagenlehner F, Werner G, Wohlfarth E, Therapy OBOSG'ROTPESFI.Antibiotics (Basel). 2022 May 31;11(6):751. doi: 10.3390/antibiotics11060751.The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010-2019.
17. Januar 2024Wohlfarth E, Kresken M, Higgins PG, Stefanik D, Wille J, Hafner D, Körber-Irrgang B, Seifert H; Study Group “Antimicrobial Resistance”…In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany.
17. Januar 2024Kresken M, Wohlfarth E, Weikel C, Butler D, Pfeifer Y, Werner G; ‘Antimicrobial Resistance’ Study Group of the Paul Ehrlich Society…Antibiotic resistance in Haemophilus influenzae isolates obtained from patients at outpatient departments in Germany, 2019/2020. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Lâm TT, Wohlfarth E, Claus H, Vogel C, Kresken M. Antibiotic resistance in Haemophilus influenzae isolates obtained from patients at…Treatment patterns and outcomes among females with uncomplicated urinary tract infection in Germany: a physician-based chart review. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Wagenlehner F, Kresken M, Naber K, Cheng WY, Catillon M, Mulgirigama A, Duh MS, Yu L, Khanal A, Joshi AV,…Antimicrobial resistance patterns and patient characteristics among females with uncomplicated urinary tract infection in Germany: a physician-based chart review. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Naber K, Kresken M, Wagenlehner F, Cheng WY, Catillon M, Mulgirigama A, Duh MS, Yu L, Khanal A, Joshi AV,…Comparative in-vitro activity of cefiderocol and four newer β-lactam/β-lactamase inhibitor combinations against two panels of clinically important Gramnegative pathogens from Germany. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Kresken M, Gatermann SG, Higgins PG, Pfeifer Y, Pfennigwerth N, Seifert H, Werner G, Wohlfarth E. Comparative in-vitro activity of cefiderocol and…In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Kresken M, Wohlfarth E, Weikel C, Butler D, Pfeifer Y, Werner G. In vitro activity of gepotidacin against urine isolates…Highly conserved mcr-1-carrying plasmids but polyclonal spread of colistin-resistant Escherichia coli from human patients and livestock products in Germany. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Neumann B, Rackwitz W, Pfennigwerth N, Hunfeld K-P, Kresken M, Leistner R, Probst-Kepper M, Hammerl JA, Werner G, Pfeifer Y.…Detection of carbapenemases in Enterobacterales: presentation of the new German guideline. 32nd European Congress of Clinical Microbiology and Infectious Diseases
14. Juni 2023Hamprecht A, Kresken M, Mack D, Molitor E, Gatermann S. Detection of carbapenemases in Enterobacterales: presentation of the new German…